Cleocin Phosphate Injection, Solution
Product Images NDC 71872-7197

8 FDA label images from Medical Purchasing Solutions, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cleocin Phosphate (NDC 71872-7197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7197-1.pdp (71872 7197 1)

71872-7197-1.pdp (71872 7197 1)
Label for Cleocin Phosphate clindamycin injection USP 600 mg/4 mL (150 mg/mL) in a 4 mL single dose vial. The label indicates intramuscular or intravenous use and storage at controlled room temperature. Distributed by Pharmacia & Upjohn Co Division of Pfizer and repackaged by Medical Purchasing Solutions, Scottsdale, AZ.*
FDA Label Image

Chemical Structure (Cleocin Solution 01)

Chemical Structure (Cleocin Solution 01)
Chemical structure diagram of clindamycin phosphate showing the molecular arrangement of atoms and chemical bonds in the active ingredient of Cleocin Phosphate injection solution.*
FDA Label Image

Logo (Cleocin Solution 02)

Logo (Cleocin Solution 02)
The label for Cleocin Phosphate injection, solution, 150 mg/mL, distributed by Pharmacia & Upjohn Co, a division of Pfizer Inc, New York, NY 10017. The image features the Pfizer Injectables logo prominently at the top.*
FDA Label Image

Figure 1 And 2 (Cleocin Solution 03)

Figure 1 And 2 (Cleocin Solution 03)
An instructional illustration showing two steps related to opening or using a medication bottle. Figure 1 depicts a hand gripping a child-resistant cap on a vial, with an arrow indicating the direction to push or twist. Figure 2 shows the cap being lifted off the vial with an upward arrow. The diagram is likely intended to demonstrate how to open the medication container safely.*
FDA Label Image

Figure 3 And 4 (Cleocin Solution 04)

Figure 3 And 4 (Cleocin Solution 04)
Illustrations depicting handling instructions for a medication vial, showing a hand removing or placing the cap on the vial. The diagrams demonstrate proper technique for opening or closing the container of injectable solution.*
FDA Label Image

Figure 5 And 6 (Cleocin Solution 05)

Figure 5 And 6 (Cleocin Solution 05)
Black-and-white line drawings depicting figures 5 and 6 of a person manipulating a small vial or syringe device with both hands, demonstrating handling or preparation steps for an injection. No text other than figure labels is visible.*
FDA Label Image

Logo (Cleocin Solution 05a)

FDA Label Image

Principal Display Panel (600 mg/4 mL Vial Label)

Principal Display Panel (600 mg/4 mL Vial Label)
Label for Cleocin Phosphate clindamycin injection, USP, 600 mg/4 mL (150 mg/mL) solution in a 4 mL vial. The label indicates intramuscular or intravenous use, single dose container, controlled room temperature storage 20° to 25°C (68° to 77°F), and reminds users to see accompanying prescribing information. Distributed by Pharma Pac International & Biopharma Co.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.